Nautilus Biotechnology, Inc.

NAUT

Nautilus Biotechnology, Inc.

NAUT

Insider Sentiment (TTM):

Last Purchase:2026-03-04Last Sale:2026-06-02Shares Purchased (TTM):132,500Shares Sold (TTM):5,000,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:52,618,411Shares Outstanding:126,634,782Institutional Ownership Pct.:41.55%

Earnings Market Reaction:

Filing Date:2026-04-28Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	15	12	24	34	33	28	4	25	26	19	74	72
Available For Sale Securities Debt Securities Curr…	81	91	108	113	106	102	136	143	156	154	109	91
Prepaid Expense And Other Assets Current	3	3	3	3	3	3	4	3	4	3	3	3
Assets Current	99	106	134	151	142	133	144	171	185	177	187	167
Property Plant And Equipment Net	4	3	4	4	4	4	4	5	5	4	4	4
Operating Lease Right Of Use Asset	27	28	25	26	27	28	29	30	32	33	34	35
Long Term Investments	-	-	-	-	-	-	-	-	-	-	92	123
Available For Sale Securities Debt Securities Nonc…	48	53	37	32	54	76	81	65	66	91	-	-
Other Assets Noncurrent	1	1	1	1	1	1	1	1	1	1	1	2
Assets	178	191	201	213	228	243	260	273	289	306	318	331
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	1	1	1	2	2	2	1	1
Operating Lease Liability Current	4	4	4	4	4	4	4	4	4	4	3	3
Liabilities Current	8	8	9	8	8	8	9	9	9	9	9	8
Operating Lease Liability Noncurrent	25	26	23	24	25	26	28	29	30	31	32	33
Liabilities	33	34	32	32	33	34	36	37	39	40	41	41
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	491	489	487	486	484	482	478	475	471	468	465	461
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	0	0	0	1	-1	-1	-0	-2	-2
Retained Earnings Accumulated Deficit	-347	-332	-318	-305	-290	-273	-255	-239	-221	-202	-185	-169
Stockholders Equity	144	157	169	181	194	209	223	235	249	265	277	290
Liabilities And Stockholders Equity	178	191	201	213	228	243	260	273	289	306	318	331
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	127	126	126	126	126	126	126	125	125	125	125	125
Shares Outstanding	127	126	126	126	126	126	126	125	125	125	125	125

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.93%	-11.97%	-32.82%	-	-	-	-	-	-	-	-	-
2025	-0.27%	-2.59%	-1.23%	-7.76%	-10.39%	27.63%	56.64%	35.66%	39.86%	25.21%	25.21%	3.72%
2024	5.91%	-3.54%	2.76%	-2.62%	15.36%	10.49%	-13.36%	-36.46%	-30.32%	-15.38%	-35.21%	-29.57%
2023	25.11%	61.67%	43.17%	1.62%	3.57%	-23.70%	16.80%	29.30%	17.58%	-5.36%	-12.14%	5.36%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	11.85	13.33	14.95	18.52	17.36	17.40	16.65	19.69	20.09	19.39	21.00	21.13
Quick Ratio	11.49	13.00	14.63	18.17	17.02	17.02	16.23	19.29	19.69	19.01	20.61	20.70
Working Capital	90.49M	98.01M	125.34M	142.59M	133.45M	125.19M	135.54M	162.25M	175.88M	167.72M	177.89M	158.81M
Leverage & Debt
Debt to Equity	0.23	0.22	0.19	0.18	0.17	0.16	0.16	0.16	0.16	0.15	0.15	0.14
Interest Coverage TTM	-9.06	-8.50	-8.27	-7.98	-7.78	-7.57	-7.17	-6.85	-6.47	-6.07	-5.84	-6.25
Debt Ratio	0.19	0.18	0.16	0.15	0.15	0.14	0.14	0.14	0.14	0.13	0.13	0.12
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.45	-0.47	-0.50	-0.52	-0.54	-0.56	-0.56	-0.56	-0.54	-0.51	-0.48	-0.47
Free Cash Flow Per Share TTM	-0.41	-0.41	-0.43	-0.45	-0.46	-0.49	-0.49	-0.48	-0.46	-0.43	-0.40	-0.39
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-16.86%	-16.64%	-10.53%	-5.68%	1.81%	11.16%	16.90%	19.57%	18.05%	9.93%	-1.87%	-5.52%
EPS Growth (1Y)	-17.18%	-17.19%	-11.14%	-6.34%	1.00%	10.71%	16.42%	18.89%	17.54%	9.64%	-2.09%	-5.60%
Valuation Metrics
P/E TTM	-8.61	-4.17	-1.70	-1.39	-1.58	-2.98	-5.09	-4.21	-5.46	-5.87	-6.57	-8.28
P/B TTM	3.40	1.57	0.63	0.51	0.56	1.01	1.60	1.25	1.47	1.41	1.42	1.66
Market Cap	491.34M	246.20M	106.73M	91.50M	108.61M	210.72M	357.54M	293.24M	367.90M	373.51M	394.79M	482.21M
Enterprise Value	475.71M	232.81M	81.85M	56.04M	74.37M	182.07M	352.13M	267.36M	341.17M	353.11M	319.68M	408.46M
Calculated Values
Free Cash Flow TTM	-51.43M	-51.97M	-53.92M	-56.29M	-58.51M	-61.27M	-61.02M	-59.81M	-57.85M	-54.15M	-50.45M	-48.36M
Net Debt	-15.63M	-13.39M	-24.88M	-35.46M	-34.24M	-28.65M	-5.41M	-25.89M	-26.73M	-20.40M	-75.11M	-73.75M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-02Sale

Owner: Ah, Bio Fund Ii, L.P., Ho…

Title: -

Shares: 5,000,000

Price/Share: $2.35

Value: $11,750,000.00

Shares Owned: 971,885

Relationship: TenPercentOwner

Ownership: Indirect

2026-03-04Purchase

Owner: Patel, Sujal M

Title: CEO, President, and Secretary

Shares: 25,000

Price/Share: $2.61

Value: $65,250.00

Shares Owned: 10,366,721

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2025-11-06Purchase

Owner: Suzuki, Kentaro

Title: Chief Marketing Officer

Shares: 4,000

Price/Share: $1.49

Value: $5,960.00

Shares Owned: 4,000

Relationship: Officer

Ownership: Direct

2025-09-08Purchase

Owner: Patel, Sujal M

Title: CEO, President, and Secretary

Shares: 83,500

Price/Share: $0.68

Value: $56,780.00

Shares Owned: 10,341,721

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2025-09-04Purchase

Owner: Murphy, Matthew B.

Title: General Counsel

Shares: 20,000

Price/Share: $0.64

Value: $12,800.00

Shares Owned: 74,140

Relationship: Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-02	Ah, Bio Fund Ii, L.P., Ho…	TenPercentOwner	-	Indirect	Sale	5,000,000	2.35	$11,750,000.00	971,885	4
2026-03-04	Patel, Sujal M	Director,Officer,TenPercentOwner	CEO, President, and Secretary	Direct	Purchase	25,000	2.61	$65,250.00	10,366,721	4
2025-11-06	Suzuki, Kentaro	Officer	Chief Marketing Officer	Direct	Purchase	4,000	1.49	$5,960.00	4,000	4
2025-09-08	Patel, Sujal M	Director,Officer,TenPercentOwner	CEO, President, and Secretary	Direct	Purchase	83,500	0.68	$56,780.00	10,341,721	4
2025-09-04	Murphy, Matthew B.	Officer	General Counsel	Indirect	Purchase	20,000	0.64	$12,800.00	74,140	4
2025-05-29	Mowry, Anna	Officer	CFO and Treasurer	Direct	Purchase	15,000	0.77	$11,550.00	83,000	4
2025-05-12	Mallick, Parag	Director,Officer,TenPercentOwner	Chief Scientist	Direct	Purchase	1,500	0.73	$1,095.00	20,493,392	4
2025-03-20	Patel, Sujal M	Director,Officer,TenPercentOwner	CEO, President, and Secretary	Direct	Purchase	23,933	1.00	$23,933.00	10,141,721	4
2024-09-23	Godwin, Mary E.	Officer	Senior VP, Operations	Direct	Sale	47,031	2.87	$134,978.97	0	4
2024-09-17	Godwin, Mary E.	Officer	Senior VP, Operations	Direct	Sale	35,000	2.85	$99,750.00	0	4
2024-03-11	Patel, Sujal M	Director,Officer,TenPercentOwner	CEO, President, and Secretary	Direct	Purchase	12,044	2.84	$34,204.96	10,064,488	4
2024-03-07	Patel, Sujal M	Director,Officer,TenPercentOwner	CEO, President, and Secretary	Direct	Purchase	18,854	2.89	$54,488.06	10,050,014	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

41.55%

Inst. Shares: 52,618,411

Shares Outstanding: 126,634,782

2025-12-31

40.16%

Inst. Shares: 50,710,303

Shares Outstanding: 126,256,583

2025-09-30

40.65%

Inst. Shares: 51,348,572

Shares Outstanding: 126,305,122

2025-06-30

42.11%

Inst. Shares: 53,138,950

Shares Outstanding: 126,204,632

2025-03-31

44.59%

Inst. Shares: 56,248,008

Shares Outstanding: 126,144,240

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	52,618,411	126,634,782	41.55%
2025-12-31	50,710,303	126,256,583	40.16%
2025-09-30	51,348,572	126,305,122	40.65%
2025-06-30	53,138,950	126,204,632	42.11%
2025-03-31	56,248,008	126,144,240	44.59%
2024-12-31	57,373,139	125,426,509	45.74%
2024-09-30	57,709,645	125,452,572	46.00%
2024-06-30	57,584,052	125,317,650	45.95%
2024-03-31	56,631,421	125,135,451	45.26%
2023-12-31	56,777,146	124,919,144	45.45%
2023-09-30	38,539,442	124,933,837	30.85%
2023-06-30	38,286,433	124,603,181	30.73%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Nautilus Biotechnology, Inc. (NAUT) — SEC Financial Statements & Analysis

Nautilus Biotechnology, Inc. (NAUT) is a laboratory analytical instruments company. Nautilus Biotechnology, Inc. trades on Nasdaq as: NAUT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Nautilus Biotechnology, Inc. reported a Debt-to-Equity ratio of 0.23x, a Price-to-Book (P/B) ratio of 3.40x (TTM), at a market cap of $491.34M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.23x
P/B TTM: 3.40x
Market Cap: $491.34M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Nautilus Biotechnology, Inc. in?

Nautilus Biotechnology, Inc. (NAUT) operates in the Laboratory Analytical Instruments industry.

What is NAUT's market cap?

Nautilus Biotechnology, Inc. (NAUT) has a market capitalization of $491.34M as of 2026-03-31.

What exchange does NAUT trade on?

Nautilus Biotechnology, Inc. (NAUT) trades on the Nasdaq.